L-364,718

Known as: L 364,718, L 364718, L364,718 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2014
0204019862014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Feeding induces increased sleep in several species, including rats. The aim of the study was to determine if CCK plays a role in… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Cholecystokinin (CCK)-A and CCK-B/gastrin receptors were evaluated with in vitro receptor autoradiography in 406 human tumors of… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
1995
1995
We have previously shown that agonist-induced Ca2+ mobilization in intestinal longitudinal muscle is mediated by ryanodine… (More)
Is this relevant?
1994
1994
The prophylactic and therapeutic effects of a potent cholecystokinin (CCK) receptor antagonist, L-364,718, on acute pancreatitis… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Recent work has suggested a role for an endogenous release of cholecystokinin (CCK) acting at either type A or type B CCK… (More)
Is this relevant?
1991
1991
To study the interdependence between gastric histamine release and acid secretion, we examined the effects of gastrin-(1-17) [G… (More)
Is this relevant?
1990
1990
Peptone, acid, and hyperosmolal saline delay gastric emptying in conscious gastric fistula rats. We have now studied the emptying… (More)
Is this relevant?
1989
1989
The cholecystokinin (CCK) receptor antagonist L 364718 was used to examine the role of CCK in control of food intake. Effects of… (More)
Is this relevant?
1988
1988
The potent and selective non-peptide cholecystokinin (CCK) antagonist L-364,718 (0.5-2.0 mg/kg s.c.) enhanced the analgesia… (More)
Is this relevant?
1987
1987
The in vivo pharmacological activity of L-364,718, a new, potent peripheral cholecystokinin (CCK) antagonist, was characterized… (More)
Is this relevant?